4 April 2016 - On 17 September 2015, the much anticipated Senate report on the Availability of new, innovative and specialist cancer drugs in Australia was released.

The inquiry preceding the report, which was triggered by concerns about inadequate and inequitable access to cancer medicines, had attracted over 200 submissions from doctors, patients, patient advocacy groups and government decision makers.

For more details, go to: https://www.mja.com.au/journal/2016/204/6/affordable-access-innovative-cancer-medicines-don-t-forget-prices?utm_source=MJA+news+alerts&utm_campaign=72ef55e571-MJA_news_vol_204_Issue_6_4_Apr_20164_1_2016&utm_medium=email&utm_term=0_8c7e70a099-72ef55e571-41328553